Breslin is a reputable investment and advisory firm based in Switzerland, specializing in providing tailored solutions for companies and investors in the Life Sciences industry. With a focus on small to large-cap global companies, Breslin offers expertise in various sectors including Biotech, Pharma, Medtech, Diagnostics, Bioenergies, Cleantech, and Agro Food. With a successful track record of over 80 transactions primarily in Biotech and Pharma markets, Breslin has proven their expertise and capability in the field.

Clients can expect a holistic approach to achieving meaningful results, leveraging Breslin's skills, experience, and integrated resources. What sets Breslin apart is their committed and experienced professionals, who work independently and confidentially to support and develop the goals of their clients and the targeted industries. Led by CEO Dr.

David Karabelnik, Breslin recognizes the significance of Life Sciences in enhancing health and survival for a growing global population. Operating in Switzerland and Germany, Breslin has two locations in Zurich and Frankfurt, serving clients across both countries. For more information, interested parties can contact Breslin via phone or email